f-ESWT vs Steroid Injection for Piriformis Syndrome

NCT ID: NCT07145554

Last Updated: 2025-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-31

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare two treatment methods for piriformis syndrome, a condition that can cause pain in the buttock and leg. Adult patients with piriformis syndrome will take part in the trial. Participants will be randomly assigned to one of two groups. One group will receive focal extracorporeal shock wave therapy (f-ESWT), a non-invasive treatment that uses sound waves. The other group will receive a steroid injection, which is a common treatment used to reduce pain and inflammation. The goal of this study is to find out which treatment is more effective in improving symptoms of piriformis syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Piriformis Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Shock wave group

Focal extracorporeal schock wave therapy

Intervention Type OTHER

Participants in this group will receive a total of 5 sessions of focal extracorporeal shock wave therapy. Each session will deliver 1000 pulses per cm² to the affected piriformis muscle.

Injection group

Steroid Injection

Intervention Type PROCEDURE

Participants in this group will receive a single injection of corticosteroid into the piriformis muscle.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Focal extracorporeal schock wave therapy

Participants in this group will receive a total of 5 sessions of focal extracorporeal shock wave therapy. Each session will deliver 1000 pulses per cm² to the affected piriformis muscle.

Intervention Type OTHER

Steroid Injection

Participants in this group will receive a single injection of corticosteroid into the piriformis muscle.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with piriformis syndrome whose pain has persisted for three months or longer despite standard medical care and activity modifications.

Exclusion Criteria

* Individuals with lumbar discopathy diagnosed by magnetic resonance imaging or electrodiagnostic study.
* Patients with coccyx pain.
* Individuals with mechanical or inflammatory disorders of the sacroiliac joint.
* Patients with pelvic region diseases.
* Pregnancy
* History of previous lumbar disc surgery.
* History of lumbar epidural block within the last 6 months.
* History of malignancy.
* Patients with signs of acute inflammation at the treatment site.
* Individuals with a cardiac pacemaker.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gulhane Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hilal Busra Aycicek

MD, Specialist in Physical Medicine and Rehabilitation

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GulhaneTRH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Shockwave Therapy for Plantar Fasciitis RCT
NCT04332471 ACTIVE_NOT_RECRUITING NA
ESWT for Primary Lipedema
NCT07240415 NOT_YET_RECRUITING NA